Loading...
PhD Boštjan Markelc

PhD Boštjan Markelc
no.: 32175 source: ARIS

researcher – active in research organisation
Research activity

Code Science Field Subfield
3.00.00  Medical sciences     
3.04.00  Medical sciences  Oncology   
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Points
670.55
A''
198.37
A'
500.71
A1/2
547.53
CI10
1,255
CImax
137
h10
18
A1
2.62
A3
4.65
Data for the last 5 years (citations for the last 10 years) on April 23, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 12.01.2024 – Project tender, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 65  1,451  1,120  17.23 
Scopus 62  1,609  1,264  20.39 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 Iva Šantek  Bologna doctoral studies    55825 
2 PhD Tim Božič  Bologna doctoral studies  10/1/2018 - 9/30/2022  51848 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (100%, RD:100%)  Institute of Oncology Ljubljana  Department of research 
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J3-50108  DEBIO 1143 has a potential to increase effectiveness of electrochemotherapy and radiotherapy in HPV positive and HPV negative Head and Neck Cancers   2023 - 2024  PhD Katarina Žnidar  2,193 
2. J4-50150  Erythrocyte membrane-based nanocarriers for gene silencing cancer therapy   2023 - 2024  PhD Nina Kostevšek  3,904 
3. L3-50111  Gene immuno-therapy of solid tumors based on mRNA encoding interleukin-12: So-rIL   2023 - 2024  PhD Maja Čemažar  2,833 
4. J3-50110  Intratumoral mRNA electrotransfer: establishment and preclinical proof of concept   2023 - 2024  PhD Katja Uršič Valentinuzzi  3,084 
5. J2-50068  Safety and efficacy of high frequency electrochemotherapy - clinical device development   2023 - 2024  PhD Matej Reberšek  3,469 
6. L7-4491  Development of integrated multi-channel artificial nose for detection of cancer   2022 - 2024  PhD Igor Muševič  5,470 
7. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   2022 - 2024  PhD Lucija Peterlin Mašič  6,049 
8. J3-4504  Uncovering the glioblastoma microenvironment to enhance the therapy   2022 - 2024  PhD Metka Novak  1,775 
9. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   2021 - 2024  PhD Gregor Serša  6,770 
10. BI-US/22-24-070  Demonstration of the possibility of linking results between three-dimensional biometric vessel models and tumor vessels in vivo   2022 - 2024  PhD Boštjan Markelc  224 
11. J3-2528  Immuno gene electrotransfer of IL-12 and IL-2 in immunologically cold/hot tumors   2020 - 2023  PhD Maja Čemažar  3,173 
12. J3-2529  Role of endothelium in tumor response to radiotherapy   2020 - 2023  PhD Boštjan Markelc  3,338 
13. J3-9269  Clinico-pharmacological approach to optimize the therapeutic bleomycin concentration in patients undergoing electrochemotherapy   2018 - 2021  PhD Gregor Serša  3,496 
14. J2-9225  Non-invasive technique for Cell Membrane Permeabilization using pulsed electromagnetic fields   2018 - 2021  PhD Damijan Miklavčič  2,900 
15. J3-8202  Time-lapse intra-vital imaging of immune response after electrochemotherapy induced in situ vaccination and Interleukin-12 gene therapy boost   2018 - 2020  PhD Maja Čemažar  3,542 
16. J4-5529  Nitroxoline and its derivatives as new antitumour drugs   2013 - 2014  PhD Janko Kos  5,950 
17. L2-4105  Development and validation of a software for numerical modeling of in vivo electroporation - in silico electroporation   2011 - 2012  PhD Damijan Miklavčič  4,817 
18. J3-4259  Preparation and validation of therapeutic plasmids without selection gene for antibiotic resistance for cancer gene therapy using inducible and tissue-specific promoters   2011 - 2012  PhD Maja Čemažar  5,846 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head No. of publications
1. P3-0003  Development and evaluation of new approaches to cancer treatment   2022 - 2024  PhD Gregor Serša  3,946 
2. I0-0059  Infrastrukturna dejavnost ONKOLOŠKI INŠTITUT (Slovene)   2022 - 2024  PhD Boštjan Markelc  554 
3. P3-0003  Development and evaluation of new approaches to cancer treatment   2018 - 2021  PhD Gregor Serša  3,264 
4. P3-0003  Development and evaluation of new approaches to cancer treatment   2009 - 2012  PhD Gregor Serša  4,018 
We were not given permission by the researcher to publish data.
Views history
Favourite